Lymphocyte Genome Sensitivity(LGS) test, is the newest blood test test developed by researchers to detect cancer in its early stages. This test not only detects some cancers earlier than ever before, but it may eliminate the need for some types of biopsies, as well as identify those more likely to develop cancer in the future. The study has been published in iThe FASEB Journal/i/a. "The test could allow earlier cancer detection, so helping to save peoples' ...
Read More
No comments:
Post a Comment